Investigation into conolidine has brought about discovery of an opioid receptor in the human body named ACKR3/CXCR7. ACKR3 appears to be the most desired target for conolidine, which also disregards the opposite 4 classical opioid receptors(3). Improvements from the comprehension of the cellular and molecular mechanisms of pain along https://thenewpainkillerconolidin63849.wizzardsblog.com/39206289/fascination-about-conolidin-to-replace-traditional-painkillers